Your browser doesn't support javascript.
loading
Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors.
Doi, Toshihiko; Matsubara, Nobuaki; Kawai, Akira; Naka, Norifumi; Takahashi, Shunji; Uemura, Hiroji; Yamamoto, Noboru.
Afiliação
  • Doi T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. tdoi@east.ncc.go.jp.
  • Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Kawai A; Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Naka N; Orthopedics (Bone Soft Part Tumor Department), Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Osaka, 541-8567, Japan.
  • Takahashi S; Medical Oncology, The Cancer Institute Hospital, JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Uemura H; Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
  • Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Invest New Drugs ; 38(4): 1175-1185, 2020 08.
Article em En | MEDLINE | ID: mdl-31820255

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Tioureia / Inibidores de Proteínas Quinases / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Tioureia / Inibidores de Proteínas Quinases / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article